Loading clinical trials...
Loading clinical trials...
Transcorneal stimulation may enable neurons to survive degeneration processes via enhanced secretion of neurotrophic substances and direct stimulation of neurons.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Okuvision GmbH
NCT07548944 · Retinitis Pigmentosa (RP), Usher Syndrome, and more
NCT05926583 · Retinitis Pigmentosa
NCT07447011 · Primary Open Angle Glaucoma, Obstructive Sleep Apnea, and more
NCT07174726 · X-Linked Retinitis Pigmentosa (XLRP)
NCT07292987 · Retinitis Pigmentosa (RP)
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions